The effects of mixed MPEG-PLA/Pluronic copolymer micelles on the bioavailability and multidrug resistance of docetaxel.
about
Can nanomedicines kill cancer stem cells?Engineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective.Poly(styrene)-b-poly(DL-lactide) copolymer-based nanoparticles for anticancer drug delivery.Nanocarrier for poorly water-soluble anticancer drugs--barriers of translation and solutions.Docetaxel-loaded solid lipid nanoparticles suppress breast cancer cells growth with reduced myelosuppression toxicityPreparation and characterization of self-assembled nanoparticles based on low-molecular-weight heparin and stearylamine conjugates for controlled delivery of docetaxel.Filamentous, mixed micelles of triblock copolymers enhance tumor localization of indocyanine green in a murine xenograft model.Ceramide and N,N,N-Trimethylphytosphingosine-Iodide (TMP-I)-Based Lipid Nanoparticles for Cancer Therapy.Combination of hydrotropic nicotinamide with nanoparticles for enhancing tacrolimus percutaneous delivery.The combined use of paclitaxel-loaded nanoparticles with a low-molecular-weight copolymer inhibitor of P-glycoprotein to overcome drug resistanceTargeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance.Preparation and characterization of curcumin-piperine dual drug loaded nanoparticlesEGFR-Targeted Polymeric Mixed Micelles Carrying Gemcitabine for Treating Pancreatic CancerApplication of the central composite design to optimize the preparation of novel micelles of harmine.How nanotechnology can enhance docetaxel therapy.The cellular uptake mechanism, intracellular transportation, and exocytosis of polyamidoamine dendrimers in multidrug-resistant breast cancer cells.Amphiphilic polymeric micelles as the nanocarrier for peroral delivery of poorly soluble anticancer drugs.Current development in nanoformulations of docetaxel.Advances in P-glycoprotein-based approaches for delivering anticancer drugs: pharmacokinetic perspective and clinical relevance.Exploring polymeric micelles for improved delivery of anticancer agents: recent developments in preclinical studies.Plasma and cellular pharmacokinetic considerations for the development and optimization of antitumor block copolymer micelles.Polymeric micelles for oral drug administration enabling locoregional and systemic treatments.Multifunctional nanomedicines: potentials and prospects.Effective Concentration of a Multikinase Inhibitor within Bone Marrow Correlates with In Vitro Cell Killing in Therapy-Resistant Chronic Myeloid Leukemia.Solubilization of flurbiprofen into aptamer-modified PEG-PLA micelles for targeted delivery to brain-derived endothelial cells in vitro.PEG-PE-based micelles co-loaded with paclitaxel and cyclosporine A or loaded with paclitaxel and targeted by anticancer antibody overcome drug resistance in cancer cells.Enhanced in vitro cellular uptake of P-gp substrate by poloxamer-modified liposomes (PMLs) in MDR cancer cells.Synergistic effect of a drug loaded electrospun patch and systemic chemotherapy in pancreatic cancer xenograft.Preparation, cell compatibility and degradability of collagen-modified poly(lactic acid).Development of plumbagin-loaded phospholipid-Tween® 80 mixed micelles: formulation, optimization, effect on breast cancer cells and human blood/serum compatibility testing.Docetaxel-loaded thermosensitive and bioadhesive nanomicelles as a rectal drug delivery system for enhanced chemotherapeutic effect.Solid lipid nanoparticles reduce systemic toxicity of docetaxel: performance and mechanism in animal.Enhancement of dissolution and oral bioavailability of lacidipine via pluronic P123/F127 mixed polymeric micelles: formulation, optimization using central composite design and in vivo bioavailability study.Pharmacokinetics and Biodistribution of GDC-0449 Loaded Micelles in Normal and Liver Fibrotic Mice.Effects of experimental hyperlipidaemia on the pharmacokinetics of docetaxel in rats.Self-Assembly Strategy for the Preparation of Polymer-Based Nanoparticles for Drug and Gene DeliveryDocetaxel-loaded composite nanoparticles formed by a temperature-induced phase transition for cancer therapyTumor Microenvironment Targeted Nanotherapy
P2860
Q27022017-6115FA83-70A2-4AA9-B573-F885CB911B50Q28073956-9FECB8F9-BB3E-4B67-8BDF-8A33578ED379Q33734382-729D9768-646C-4082-A518-488E72BBADF0Q33962553-7643B2E2-AE17-4B3B-AEAB-C55FA3ED01C9Q34394402-68208B10-A92E-4858-8EA4-B65236C2519DQ34721483-1DD311BD-94FF-4E1B-A47C-95C5D987E7E7Q35667084-DAB2C3FA-8D75-4BA0-8BA2-36DB5875859EQ35764089-2DE7157F-84BC-48C0-8FB1-3E433BE2E5A6Q36118185-EEAF710D-E21D-4A52-87C6-DDB2925E660FQ36567533-E1B8BB27-E768-4F29-8335-3134DCE23232Q36680180-5877D9DB-E76D-4E67-9B5F-04CF0AA8D082Q36719569-5319CA95-0CC1-4D54-A919-533C9E84CD61Q36791698-E9665AB9-E8EA-4CB2-BCBF-28E78AAA60C3Q36839361-8739D897-26FA-43E5-AF1D-4B8A8FCBF5E8Q37091683-8D21148F-7EE3-4F99-9CF0-F433BF5147C0Q37158861-4BB9356B-C1B9-4118-8D76-2FDFBCD472ECQ38004050-329446F4-AD31-4A5C-8F02-120FE26B3E98Q38019047-DECD07E5-92B4-423F-9AD2-9370B1FFCCD0Q38167822-4C3867FB-794C-4B71-AAF1-359582ECB67DQ38168377-756A8E6A-9C09-4591-AC73-0BD5F291221EQ38248809-6ACE3F9A-249A-4C30-8DF3-9647CDEBD7F0Q38250152-E2FA1649-8909-42AC-B3CE-80BA989BC0CDQ38383487-B20AE2AF-18F2-4825-BE86-F18D75FFCDA2Q38796480-9FBFF6A6-5019-4B30-9255-12732E3C5593Q39177694-E893B8E5-3257-4BCF-8F93-FC235B39383CQ39364129-12CC7B78-EBE6-41B1-BC15-55DE62C769D6Q39504361-5173CB9C-A790-4C16-AA3F-9E307478204CQ42366470-3509F6DE-A86A-4061-80A8-CAB5BAFC4C7DQ42831551-91E3314C-0545-47AA-A711-68A319BEC523Q44794686-390AF18F-7F55-4352-B4C3-16DDCE9EC48AQ46396503-8BB133F9-D830-43B3-A304-7563EB2E53D1Q46729488-6BEE4914-45E5-4A61-B10C-A2C10DD0F95AQ49591635-46D29251-FC6A-44E0-AF14-B68E16CA5FDEQ51000204-4C86548C-3645-4789-8F7E-03DC30915EC4Q54207094-6E00059D-960A-4C71-94A0-0D9B3306487BQ57343394-C9396239-DE1E-42C9-B4A0-5DAA201885A2Q57371928-6C20C92C-3200-4DC1-86EC-E07BC849D99AQ59133567-63A266A0-8E63-4E4C-A25E-781277FEB3B5
P2860
The effects of mixed MPEG-PLA/Pluronic copolymer micelles on the bioavailability and multidrug resistance of docetaxel.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The effects of mixed MPEG-PLA/ ...... idrug resistance of docetaxel.
@ast
The effects of mixed MPEG-PLA/ ...... idrug resistance of docetaxel.
@en
The effects of mixed MPEG-PLA/ ...... idrug resistance of docetaxel.
@nl
type
label
The effects of mixed MPEG-PLA/ ...... idrug resistance of docetaxel.
@ast
The effects of mixed MPEG-PLA/ ...... idrug resistance of docetaxel.
@en
The effects of mixed MPEG-PLA/ ...... idrug resistance of docetaxel.
@nl
prefLabel
The effects of mixed MPEG-PLA/ ...... idrug resistance of docetaxel.
@ast
The effects of mixed MPEG-PLA/ ...... idrug resistance of docetaxel.
@en
The effects of mixed MPEG-PLA/ ...... idrug resistance of docetaxel.
@nl
P2093
P1433
P1476
The effects of mixed MPEG-PLA/ ...... idrug resistance of docetaxel.
@en
P2093
Chang-Koo Shim
Chao-Feng Mu
Chul Soon Yong
Dae-Duk Kim
Han-Gon Choi
Prabagar Balakrishnan
Suk-Jae Chung
Yong-Bok Lee
Yong-Mei Yin
P304
P356
10.1016/J.BIOMATERIALS.2009.11.102
P577
2010-01-19T00:00:00Z